Approval of exsig™ COVID-19 Direct test in the UK under CTDA legislation
Novacyt S.A. (AIM:NCYT) Trading update and progress against strategy
Trading update and progress against strategy for H1 2022
Novacyt S.A. (AIM:NCYT) Launch of monkeypox assay
Paris, France and Camberley, UK – 28 June 2022 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces the launch of its research-use-only
Novacyt S.A. (AIM:NCYT) DHSC dispute update
Paris, France and Camberley, UK – 16 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with
Novacyt S.A. (AIM:NCYT) DHSC dispute update
Paris, France and Camberley, UK – 26 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with
Novacyt S.A. (AIM:NCYT) Approval of COVID-19 test under CTDA legislation
Approval of second direct-to-PCR COVID-19 test in the UK under CTDA legislation
Novacyt S.A. (AIM: NCYT) Approval of COVID-19 test under CTDA legislation
Paris, France and Camberley, UK – 17 February 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s PROmate ® COVID-19 2G
Novacyt S.A. (NCYT.L) Strategy and Full Year 2021 Trading Update
Full-year revenue and EBITDA in line with expectations
Novacyt S.A. (NCYT.L) Approval of COVID-19 test under CTDA legislation
Paris, France and Camberley, UK – 26 November 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 2
Novacyt S.A. (NCYT.L) Proposed accounting treatment of DHSC dispute
Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
Novacyt S.A. (NCYT.L) Notice of AGM
Paris, France and Camberley, UK – 20 August 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces that its Annual General Meeting
Novacyt S.A. (NCYT.L) Half Year Update, Investor meeting at 13:00 BST / 14:00 CEST
Paris, France and Camberley, UK – 18 August 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces a half year update in